NASS 2019 Annual Meeting

Abstract Presentations: Biomechanics and Basic Science I (Room Room W471ab)

Moderator: Zorica Buser, PhD

 

1. Comparison of serum cytokine concentrations in patients with acute sciatica secondary to lumbar disc herniation choosing surgery with those choosing nonoperative treatment
Paul B. Bishop, MD, PhD, DC1; John Street, MD, PhD2; Jeffrey A. Quon, PhD, DC3; Brian E. Arthur, DC, MSc3; Gabriella M. Petrollini, BS4; Melissa Nadeau, MD, MHS, FRCSC2; Tamir Ailon, MD, MPH5; Nicolas Dea, MD, MSc, FRCSC2; Charles G. Fisher, MD, FRCSC, MHS6; Brian K. Kwon, MD, PhD, FRCSC2
1Blusson Spine Centre, Vancouver, BC, Canada; 2Blusson Spinal Cord Center, Vancouver, BC, Canada; 3Vancouver, BC, Canada; 4UBC School of Population and Public Health, Vancouver, BC, Canada; 5Vancouver Spine Surgery Institute, Vancouver, BC, Canada; 6Vancouver General Hospital, Vancouver, BC, Canada

 

FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.

 

2. 3D-printed titanium: a surface optimization analysis
Antonio T. Brecevich, MD; Christina Dowe, BS; Frank P. Cammisa, MD; Celeste Abjornson, PhD
Hospital for Special Surgery, New York, NY, US

 

FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.

 

3. Fatigue analysis of multilevel anterior cervical fusion with standalone anchored spacer versus interbody cage with anterior plate
Aymen Rashid, MD1; Nathaniel R. Ordway, MS2; James B. Allen3; Satyajit Marawar, MD4; William F. Lavelle, MD5
1SUNY Upstate University Hospital, Syracuse, NY, US; 2SUNY Upstate Medical University, Syracuse, NY, US; 3Syracuse, NY, US; 4Syracuse VAHCN, Syracuse, NY, US; 5Upstate Orthopedics, East Syracuse, NY, US

 

FDA Device/Drug Status: standalone anchored spacer (Approved for this indication), interbody cage with anterior place (Approved for this indication)

 

4. Lumbosacral TLIF but not ALIF increases proximal junction motion in long segment constructs
Randall J. Hlubek, MD1; Jakub Godzik, MD2; Anna G. Newcomb, MS3; Jennifer Lehrman, MS1; Bernardo De Andrada Pereira, MD2; Brian Kelly, PhD1; Jay D. Turner, MD, PhD4
1Barrow Neurological Institute, Phoenix, AZ, US; 2Phoenix, AZ, US; 3St. Joseph's Hospital and Medical Center, Phoenix, AZ, US; 4Barrow Brain and Spine, Phoenix, AZ, US

 

FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.

 

Discussion

 

5. A biomechanical investigation of the sacroiliac joint in the setting of lumbosacral fusion: the impact of pelvic fixation versus sacroiliac joint fixation
Harry M. Mushlin, MD1; Gerald Hayward, BS2; Daina M. Brooks, BS3; Bryan Ferrick, BS4; Stephen Carbine5; Brandon Bucklen, PhD2; Charles A. Sansur, MD6
1University of Maryland School of Medicine, Department of Neurosurgery, Baltimore, MD, US; 2Globus Medical Inc., Audubon, PA, US; 3Medstar Union Memorial Hospital, Baltimore, MD, US; 4Drexel University School of Biomedical Engineering, Philadelphia, PA, US; 5Baltimore, MD, US; 6University of Maryland, Towson, MD, US

 

FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.

 

6. Biomechanical investigation of the potential development and prevention of scoliosis following various sizes of chest wall resection
Zackery W. Witte, MD1; Jonathan M. Mahoney, BS2; Jonathan Harris2; Hassaan P. Sheikh, BS2; Brandon Bucklen, PhD2; Rex A. Marco, MD3; Varan Haghshenas, MD4
1Houston, TX, US; 2Globus Medical Inc., Audubon, PA, US; 3Houston Methodist Orthopedics & Sports Medicine, Houston, TX, US; 4Houston Methodist Hospital, Houston, TX, US

 

FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.

 

7. Eccentric kinematic patterns of the sacroiliac junction following lumbopelvic reconstruction
Daina M. Brooks, BS1; Bryan W. Cunningham, PhD1; P. Justin Tortolani, MD2
1MedStar Union Memorial Hospital, Baltimore, MD, US; 2Baltimore, MD, US

 

FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.

 

8. The immune response of two separate polymer spinal interbody device materials
Boyle C. Cheng, PhD1; Isaac Swink, MS2; Daniel T. Altman, MD3
1Allegheny General Hospital, Pittsburgh, PA, US; 2Pittsburgh, PA, US; 3Allegheny Health Network, Pittsburgh, PA, US

 

FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.

 

9. Insulin protects intervertebral discs stimulated with diabetes-related cytokines
Mark Lambrechts, MD1; Anna E. Skrade1; Emma C. LePage2; Aaron M. Stoker, PhD3; Christina L. Goldstein, MD, FRCSC1; Theodore J. Choma, MD4; James L. Cook, DVM, PhD5
1Missouri Orthopaedic Institute, Columbia, MO, US; 2Columbia, MO, US; 3University of Missouri School of Medicine, Thompson Laboratory for Regenerative Orthopaedics, Columbia, MO, US; 4Missouri Spine Center, Columbia, MO, US; 5University of Missouri Department of Orthopaedic Surgery, Columbia, MO, US

 

FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.

 

Discussion